Nellone Therapeutics, Inc.
KNOXVILLE, TN · Biotech · Private
Recombinant human NELL1 protein therapeutic to promote lung tissue healing and reduce inflammation in viral respiratory infections
- Grants
- $242K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 15
- 5 granted · 10 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Regulation of Hyperinflammation and Cell Survival Under Hypoxia with NELL1/NV1: A Therapy for Severe Lung Tissue Damage in Viral Infections (COVID-19) | $242,342 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1324 | NRG Therapeutics | — | — |
| 1325 | Senseion Therapeutics, Inc. | — | — |
| 1326 | Sequegenics LLC | — | — |
| 1327 | Nellone Therapeutics, Inc. | — | — |
| 1328 | Prox Capital Holdings, LLC | — | $800K |
| 1329 | Parabilis Medicines | — | — |
| 1330 | Mozart Therapeutics | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods And Compositions For Regenerating Tissuesgranted
- Methods And Compositions For Regenerating Tissuesgranted
- Methods And Compositions For Regenerating Tissuesgranted
- Methods And Compositions For Treating Muscle Atrophyapplication
- Methods And Compositions For Treating Tissue Damage Resulting From Viral Infectionsapplication
- Composite Stent Apparatus And Fabrication Methodapplication
- Methods And Compositions For Regenerating Tissuesgranted
- Methods And Compositions For Regenerating Tissuesgranted
- Methods To Treat Or Prevent A Skin Condition Using Nelli Peptideapplication
- Methods And Compositions For Treating Tissue Damage Resulting From Viral Infectionsapplication
- Methods And Compositions For Treating Muscle Atrophyapplication
- Methods And Compositions For Treating Tissue Damage Resulting From Viral Infectionsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.